Previous close | 4.71 |
Open | 4.40 |
Bid | 5.60 |
Ask | 6.00 |
Strike | 230.00 |
Expiry date | 2024-07-19 |
Day's range | 4.40 - 5.38 |
Contract range | N/A |
Volume | |
Open interest | 128 |
Each of Zimmer Biomet's (ZBH) geographic segments records strong year-over-year sales growth on a reported basis, as well as at CER.
Envista (NVST) registers a year-over-year decline in both segments in the first quarter of 2024.
Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.